IE
FHTX icon

Israel Englander’s Foghorn Therapeutics FHTX Stock Holding History

Israel Englander’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
53,509
+23,957
+81% +$106K ﹤0.01% 5183
2026
Q1 		$141K Sell
29,552
-179,013
-86% -$983K ﹤0.01% 5274
2025
Q4 		$1.13M Buy
208,565
+29,774
+17% +$135K ﹤0.01% 4401
2025
Q3 		$874K Buy
178,791
+160,197
+862% +$849K ﹤0.01% 4715
2025
Q2 		$87.4K Sell
18,594
-2,062
-10% -$8.62K ﹤0.01% 5530
2025
Q1 		$75.4K Sell
20,656
-71,984
-78% -$328K ﹤0.01% 5483
2024
Q4 		$437K Buy
92,640
+34,306
+59% +$250K ﹤0.01% 4846
2024
Q3 		$543K Buy
58,334
+36,380
+166% +$263K ﹤0.01% 4762
2024
Q2 		$126K Sell
21,954
-40,093
-65% -$239K ﹤0.01% 5263
2024
Q1 		$416K Buy
+62,047
New +$344K ﹤0.01% 4930
2023
Q2 		– Sell
-37,885
Closed -$235K – 6268
2023
Q1 		$235K Sell
37,885
-145,882
-79% -$955K ﹤0.01% 5076
2022
Q4 		$1.17M Buy
183,767
+53,266
+41% +$402K ﹤0.01% 4008
2022
Q3 		$1.12M Sell
130,501
-8,312
-6% -$107K ﹤0.01% 4239
2022
Q2 		$1.89M Sell
138,813
-23,505
-14% -$303K ﹤0.01% 3765
2022
Q1 		$2.47M Buy
162,318
+25,144
+18% +$345K ﹤0.01% 3674
2021
Q4 		$3.14M Buy
137,174
+44,541
+48% +$640K ﹤0.01% 3334
2021
Q3 		$1.29M Sell
92,633
-103,129
-53% -$1.14M ﹤0.01% 4404
2021
Q2 		$2.09M Buy
195,762
+33,644
+21% +$367K ﹤0.01% 3905
2021
Q1 		$2.14M Sell
162,118
-52,744
-25% -$864K ﹤0.01% 3471
2020
Q4 		$4.36M Buy
+214,862
New +$4.12M ﹤0.01% 2574

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Israel Englander's FHTX Position: Q2 2026 in Review

Israel Englander increased its Foghorn Therapeutics (FHTX) stake by 81% in Q2 2026, buying an estimated $106K and bringing the position to 53,509 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #5183.

Israel Englander first reported a position in FHTX in Q4 2020 and has held it in 20 quarters since. The position peaked at $4.36M in Q4 2020. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Israel Englander held 53,509 shares of Foghorn Therapeutics worth $261K as of Q2 2026.
  • Israel Englander bought 23,957 Foghorn Therapeutics shares in Q2 2026, an estimated $106K.
  • Foghorn Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5183 holding.
  • Israel Englander first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Israel Englander's Foghorn Therapeutics position peaked at $4.36M in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.